Mehmet Reşat Ceylan

8PUBLICATIONS
71CO-AUTHORS
Major global burdens of diseasePharmacogenomicsDisease surveillancePredictive and prognostic markersCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 16, 2025
Real-Life Experience of Hepatitis C Treatment with Direct-Acting Antivirals in Genotypes 2 and 3.

Sibel Yıldız Kaya, Behice Kurtaran, Nefise Öztoprak Çuvalcı

|Oct 14, 2024
The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data.

Yunus Gürbüz, Aysel Kocagül-Çelikbaş, Nefise Öztoprak

|Jun 17, 2022
Are H1 and H3 haplotypes of endothelial protein C receptor (PROCR) an important factor in contracting COVID-19?

Mehmet Reşat Ceylan, Nazım Kankılıç, Özlem Öz

Pageof 2